Anvendelse av en kombinasjon av forbindelser med partiell dopamin D2 reseptoragonistaktivitet samt serotonin- og/eller noradrenalininhibitoraktivitet til behandling av psykiatriske eller neurologiske forstyrrelser.

摘要

The invention relates to the use of a compound or a combination of compounds having partial dopamine-D₂ receptor agonistic activity and serotonin and/or noradrenaline reuptake inhibitory activity, for the preparation of a pharmaceutical composition for the treatment of psychiatric and/or neurologic disorders caused by disturbances of the major monoaminergic (dopamine, serotonin and/or nordrenaline) systems or that can be treated via manipulation of those systems.